Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
NewsTrigger Warning: This article mentions child sexual abuse and drug use. Journalism has existed ever since people first banded together in complex social groups. From cave drawings telling primitive band communities about discoveries and new hunting grounds, th
LeadershipWith the leadership of newly appointed Glen Foster, Managing Director for the UK and Northern Europe, the move will be powered by Libeo’s competitive advantage and its innovative differentiating features.
TechnologyImage Credit Enterprise buyers are no longer evaluating identity verification on speed alone. Digital onboarding platforms must also support compliance workflows, fraud controls and a consistent user experience at scale. Some platforms build identity verificat
LegalCDG is an English law firm based in the City of London and provides a range of services to the shipping and oil and gas sectors.
NewsBI4ALL is specialised in digital transformation and data strategy, using services such as analytics, big data, and software engineering to ably assist its numerous clients.
InnovationGlobalCare Clinical Trials, Ltd is the leading global provider of ambulant health care services for clinical trials.
NewsNew York City is synonymous with success. Wall Street titans, real estate moguls, and entrepreneurs who’ve built their empires all call it home. But behind the private jets and Fifth Avenue penthouses lies a reality those of more modest means rarely have
Strategy5 Actionable Tips on Improving Your Digital Marketing Strategy with Animated Videos | Video Marketing Strategy
NewsArtificial Intelligence (AI) is transforming the financial markets, offering sophisticated tools for buying stocks and enhancing trading strategies. One platform leading this revolution is BuyStocks.ai, which provides access to advanced AI trading tools and in
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
